Future: Products in Pipeline

ImmunoScience is also developing a recombinant apo-lipo-protein to be used in dissolving coronary artery and other arteriosclerotic plaques, a recombinant compound that would preve nt the progression of Alzheimer's disease and an immunologically active agent that would prevent attacks of multiple sclerosis as well as the destruction caused by them. The actual compounds to be used and methods of their development and testing currently have no patent protection and therefore will not be disclosed here. Some of these products are in Phase II equivalent clinical studies abroad.

Please note that ImmunoScience's products are the subject of many US and International patent applications. This document does not convey any rights to develop, manufacture, use or sell anything described herein.